SHISEIDO FUTURE SOLUTION LX DAYTIME PROTECTIVE

Manufacturer: SHISEIDO AMERICA INC. | Davlyn Industries Inc
Effective date: 2013-02-05
Label type: HUMAN OTC DRUG LABEL
Version: 2
Source: legacy-cache
Hydrated at: 2026-08-02 01:41:46

Label at a glance#

ProductSHISEIDO FUTURE SOLUTION LX DAYTIME PROTECTIVE

Active ingredientAVOBENZONE, OCTINOXATE, OCTOCRYLENE

Label structure9 sections

Indications and uses

helps prevent sunburn if used as directed with other sun protection measures (see Directions ), decreases the risk of skin cancer and early skin aging caused by the sun

Dosage and administration

For sunscreen use: apply liberally 15 minutes before sun exposure use a water resistant sunscreen if swimming or sweating reapply at least every 2 hours Sun Protection Measures . Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a broad spectrum SPF of 15 or higher and other sun protection measures including: limit time in the su...

Storage and handling

protect this product in this container from excessive heat and direct sun.

Contacts and useful links#

PhoneLabel contact1-800-906-7503

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Drug Facts

OTC - ACTIVE INGREDIENT SECTION

OTC - PURPOSE SECTION

ACTIVE INGREDIENTS:	Purpose
AVOBENZONE 2.5%	Sunscreen
OCTINOXATE 7.4%	Sunscreen
OCTOCRYLENE 2.0%	Sunscreen

Uses

INDICATIONS & USAGE SECTION

helps prevent sunburn
if used as directed with other sun protection measures (see Directions), decreases the risk of skin cancer and early skin aging caused by the sun

Warnings

WARNINGS SECTION

For external use only

OTC - DO NOT USE SECTION

Do not use on damaged or broken skin

OTC - WHEN USING SECTION

When using this product keep out of eyes. Rinse with water to remove.

OTC - STOP USE SECTION

Stop use and ask a doctor if rash occurs

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. If product is swallowed, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

For sunscreen use:

apply liberally 15 minutes before sun exposure
use a water resistant sunscreen if swimming or sweating
reapply at least every 2 hours
Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a broad spectrum SPF of 15 or higher and other sun protection measures including:
- limit time in the sun, especially from 10 a.m. – 2 p.m.
- wear long-sleeve shirts, pants, hats, and sunglasses
children under 6 months: Ask a doctor

Inactive Ingredients

INACTIVE INGREDIENT SECTION

WATER, DIPROPYLENE GLYCOL, DIMETHICONE, GLYCERIN, SD ALCOHOL 40-B, HYDROGENATED POLYDECENE, BEHENYL ALCOHOL, DIPHENYLSILOXY PHENYL TRIMETHICONE, SIMMONDSIA CHINENSIS (JOJOBA) SEED OIL, POLYBUTYLENE GLYCOL/PPG-9/1 COPOLYMER, POLYSORBATE 60, GLYCERYL STEARATE, PEG-20, SILICA, ERYTHRITOL, XANTHAN GUM, PIPERIDINEPROPIONIC ACID, SACCHAROMYCES FERMENT LYSATE FILTRATE, GLYCINE, MAGNESIUM ASCORBYL PHOSPHATE, ARGININE HCl, SODIUM ACETYLATED HYALURONATE, ONONIS SPINOSA ROOT EXTRACT, AVERRHOA CARAMBOLA LEAF EXTRACT, HIBISCUS ESCULENTUS FRUIT EXTRACT, CAMELLIA SINENSIS LEAF EXTRACT, SODIUM METHYL STEAROYL TAURATE, TRIETHANOLAMINE, BUTYLENE GLYCOL, DISTEARYLDIMONIUM CHLORIDE, SODIUM METAPHOSPHATE, ALCOHOL, ISOPROPYL ALCOHOL, BHT, TOCOPHEROL, PHENOXYETHANOL, FRAGRANCE, IRON OXIDES,

Other information

STORAGE AND HANDLING SECTION

protect this product in this container from excessive heat and direct sun.

Questions or comments?

OTC - QUESTIONS SECTION

Call toll free 1-800-906-7503

PRINCIPAL DISPLAY PANEL - 50.2 g Jar Carton

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

SHISEIDO

FUTURE SOLUTION LX

Daytime Protective Cream

BROAD SPECTRUM SPF 18

SUNSCREEN

Principal Display Panel - 50.2 g Jar Carton

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
52686-329-50	2023-11-28	C162847	48780-1	9d75b9d0-0f82-f424-e053-dadaa90a57ce	SHISEIDO FUTURE SOLUTION LX DAYTIME PROTECTIVE
52686-329-51	2023-11-28	C162847	48780-1	9d75b9d0-0f82-f424-e053-dadaa90a57ce	SHISEIDO FUTURE SOLUTION LX DAYTIME PROTECTIVE
52686-329-52	2023-11-28	C162847	48780-1	9d75b9d0-0f82-f424-e053-dadaa90a57ce	SHISEIDO FUTURE SOLUTION LX DAYTIME PROTECTIVE
52686-329-50	2020-01-31	C162847	48780-1	9d75b9d0-0f82-f424-e053-dadaa90a57ce	SHISEIDO FUTURE SOLUTION LX DAYTIME PROTECTIVE
52686-329-51	2020-01-31	C162847	48780-1	9d75b9d0-0f82-f424-e053-dadaa90a57ce	SHISEIDO FUTURE SOLUTION LX DAYTIME PROTECTIVE
52686-329-52	2020-01-31	C162847	48780-1	9d75b9d0-0f82-f424-e053-dadaa90a57ce	SHISEIDO FUTURE SOLUTION LX DAYTIME PROTECTIVE

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
AVOBENZONE	ACTIVE INGREDIENT	G63QQF2NOX	2
OCTINOXATE	ACTIVE INGREDIENT	4Y5P7MUD51	2
OCTOCRYLENE	ACTIVE INGREDIENT	5A68WGF6WM	2
AVOBENZONE	ACTIVE MOIETY	G63QQF2NOX	2
OCTINOXATE	ACTIVE MOIETY	4Y5P7MUD51	2
OCTOCRYLENE	ACTIVE MOIETY	5A68WGF6WM	2
.ALPHA.-TOCOPHEROL	INACTIVE INGREDIENT	H4N855PNZ1	2
ALCOHOL	INACTIVE INGREDIENT	3K9958V90M	2
ARGININE HYDROCHLORIDE	INACTIVE INGREDIENT	F7LTH1E20Y	2
AVERRHOA CARAMBOLA LEAF	INACTIVE INGREDIENT	HB7UP0QK1T	2
BUTYLATED HYDROXYTOLUENE	INACTIVE INGREDIENT	1P9D0Z171K	2
BUTYLENE GLYCOL	INACTIVE INGREDIENT	3XUS85K0RA	2
DIMETHICONE	INACTIVE INGREDIENT	92RU3N3Y1O	2
DIPHENYLSILOXY PHENYL TRIMETHICONE	INACTIVE INGREDIENT	I445L28B12	2
DIPROPYLENE GLYCOL	INACTIVE INGREDIENT	E107L85C40	2
DISTEARYLDIMONIUM CHLORIDE	INACTIVE INGREDIENT	OM9573ZX3X	2
DOCOSANOL	INACTIVE INGREDIENT	9G1OE216XY	2
ERYTHRITOL	INACTIVE INGREDIENT	RA96B954X6	2
FERRIC OXIDE RED	INACTIVE INGREDIENT	1K09F3G675	2
FERRIC OXIDE YELLOW	INACTIVE INGREDIENT	EX438O2MRT	2
GLYCERIN	INACTIVE INGREDIENT	PDC6A3C0OX	2
GLYCERYL MONOSTEARATE	INACTIVE INGREDIENT	230OU9XXE4	2
GLYCINE	INACTIVE INGREDIENT	TE7660XO1C	2
GREEN TEA LEAF	INACTIVE INGREDIENT	W2ZU1RY8B0	2
HYDROGENATED POLYDECENE (550 MW)	INACTIVE INGREDIENT	U333RI6EB7	2
ISOPROPYL ALCOHOL	INACTIVE INGREDIENT	ND2M416302	2
JOJOBA OIL	INACTIVE INGREDIENT	724GKU717M	2
MAGNESIUM ASCORBYL PHOSPHATE	INACTIVE INGREDIENT	0R822556M5	2
ONONIS SPINOSA ROOT	INACTIVE INGREDIENT	FD2FMC53M1	2
PHENOXYETHANOL	INACTIVE INGREDIENT	HIE492ZZ3T	2
PIPERIDINEPROPIONIC ACID	INACTIVE INGREDIENT	6L69A7VPHO	2
POLYETHYLENE GLYCOL 1000	INACTIVE INGREDIENT	U076Q6Q621	2
POLYSORBATE 60	INACTIVE INGREDIENT	CAL22UVI4M	2
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	2
SODIUM METHYL STEAROYL TAURATE	INACTIVE INGREDIENT	JFM219LJ55	2
SODIUM POLYMETAPHOSPHATE	INACTIVE INGREDIENT	P1BM4ZH95L	2
TROLAMINE	INACTIVE INGREDIENT	9O3K93S3TK	2
WATER	INACTIVE INGREDIENT	059QF0KO0R	2
XANTHAN GUM	INACTIVE INGREDIENT	TTV12P4NEE	2

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 38 matching rows.

SHISEIDO FUTURE SOLUTION LX DAYTIME PROTECTIVE
AVOBENZONE, OCTINOXATE, and OCTOCRYLENE
AVOBENZONE
OCTINOXATE
OCTOCRYLENE
WATER
DIPROPYLENE GLYCOL
DIMETHICONE
GLYCERIN
HYDROGENATED POLYDECENE (550 MW)
DOCOSANOL
DIPHENYLSILOXY PHENYL TRIMETHICONE
JOJOBA OIL
POLYSORBATE 60
GLYCERYL MONOSTEARATE
POLYETHYLENE GLYCOL 1000
SILICON DIOXIDE
ERYTHRITOL
XANTHAN GUM
PIPERIDINEPROPIONIC ACID
GLYCINE
MAGNESIUM ASCORBYL PHOSPHATE
ARGININE HYDROCHLORIDE
ONONIS SPINOSA ROOT
AVERRHOA CARAMBOLA LEAF
GREEN TEA LEAF
SODIUM METHYL STEAROYL TAURATE
TROLAMINE
BUTYLENE GLYCOL
DISTEARYLDIMONIUM CHLORIDE
SODIUM POLYMETAPHOSPHATE
ALCOHOL
ISOPROPYL ALCOHOL
BUTYLATED HYDROXYTOLUENE
.ALPHA.-TOCOPHEROL
PHENOXYETHANOL
FERRIC OXIDE YELLOW
FERRIC OXIDE RED

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
52686-329	52686-329-50, 52686-329-51, 52686-329-52

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 36 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
AVOBENZONE	G63QQF2NOX	ACTIB
OCTINOXATE	4Y5P7MUD51	ACTIB
OCTOCRYLENE	5A68WGF6WM	ACTIB
WATER	059QF0KO0R	IACT
DIPROPYLENE GLYCOL	E107L85C40	IACT
DIMETHICONE	92RU3N3Y1O	IACT
GLYCERIN	PDC6A3C0OX	IACT
HYDROGENATED POLYDECENE (550 MW)	U333RI6EB7	IACT
DOCOSANOL	9G1OE216XY	IACT
DIPHENYLSILOXY PHENYL TRIMETHICONE	I445L28B12	IACT
JOJOBA OIL	724GKU717M	IACT
POLYSORBATE 60	CAL22UVI4M	IACT
GLYCERYL MONOSTEARATE	230OU9XXE4	IACT
POLYETHYLENE GLYCOL 1000	U076Q6Q621	IACT
SILICON DIOXIDE	ETJ7Z6XBU4	IACT
ERYTHRITOL	RA96B954X6	IACT
XANTHAN GUM	TTV12P4NEE	IACT
PIPERIDINEPROPIONIC ACID	6L69A7VPHO	IACT
GLYCINE	TE7660XO1C	IACT
MAGNESIUM ASCORBYL PHOSPHATE	0R822556M5	IACT
ARGININE HYDROCHLORIDE	F7LTH1E20Y	IACT
ONONIS SPINOSA ROOT	FD2FMC53M1	IACT
AVERRHOA CARAMBOLA LEAF	HB7UP0QK1T	IACT
GREEN TEA LEAF	W2ZU1RY8B0	IACT
SODIUM METHYL STEAROYL TAURATE	JFM219LJ55	IACT
TROLAMINE	9O3K93S3TK	IACT
BUTYLENE GLYCOL	3XUS85K0RA	IACT
DISTEARYLDIMONIUM CHLORIDE	OM9573ZX3X	IACT
SODIUM POLYMETAPHOSPHATE	P1BM4ZH95L	IACT
ALCOHOL	3K9958V90M	IACT
ISOPROPYL ALCOHOL	ND2M416302	IACT
BUTYLATED HYDROXYTOLUENE	1P9D0Z171K	IACT
.ALPHA.-TOCOPHEROL	H4N855PNZ1	IACT
PHENOXYETHANOL	HIE492ZZ3T	IACT
FERRIC OXIDE YELLOW	EX438O2MRT	IACT
FERRIC OXIDE RED	1K09F3G675	IACT

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 7 · 404 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
GLYCERIN	GLYCERIN	PDC6A3C0OX	INJECTION / INTRADERMAL	1.6 %w/v		Exact identifier — unii candidate 75 equally ranked IID candidates
GLYCERYL MONOSTEARATE	GLYCERYL MONOSTEARATE	230OU9XXE4	LOTION / TOPICAL		177 mg	Exact identifier — unii candidate 21 equally ranked IID candidates
GLYCERYL MONOSTEARATE	GLYCERYL MONOSTEARATE	230OU9XXE4	LIQUID / TOPICAL	1 %w/w		Exact identifier — unii candidate 21 equally ranked IID candidates
FERRIC OXIDE RED	FERRIC OXIDE RED	1K09F3G675	TABLET, CHEWABLE / ORAL		2 mg	Exact identifier — unii candidate 21 equally ranked IID candidates
BUTYLATED HYDROXYTOLUENE	BUTYLATED HYDROXYTOLUENE	1P9D0Z171K	SHAMPOO / TOPICAL	0.1 %w/w		Exact identifier — unii candidate 32 equally ranked IID candidates
GLYCERIN	GLYCERIN	PDC6A3C0OX	SYSTEM / IONTOPHORESIS	168.1 mg		Exact identifier — unii candidate 75 equally ranked IID candidates
GLYCINE	GLYCINE	TE7660XO1C	PASTE, DENTIFRICE / DENTAL	0.34 %w/w		Exact identifier — unii candidate 20 equally ranked IID candidates
ALCOHOL	ALCOHOL	3K9958V90M	SOLUTION, CONCENTRATE / ORAL	150.68 mg/1ml		Exact identifier — unii candidate 59 equally ranked IID candidates
ISOPROPYL ALCOHOL	ISOPROPYL ALCOHOL	ND2M416302	TABLET, EXTENDED RELEASE / ORAL	NA		Exact identifier — unii candidate 9 equally ranked IID candidates
ALCOHOL	ALCOHOL	3K9958V90M	SOLUTION / INTRAVESICAL		7892 mg	Exact identifier — unii candidate 59 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	GRANULE, FOR SUSPENSION / ORAL		200 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
ALCOHOL	ALCOHOL	3K9958V90M	LIQUID / RESPIRATORY (INHALATION)	5 %w/w		Exact identifier — unii candidate 59 equally ranked IID candidates
GLYCERIN	GLYCERIN	PDC6A3C0OX	INJECTION, EMULSION / INTRAVENOUS		24100 mg	Exact identifier — unii candidate 75 equally ranked IID candidates
GLYCERIN	GLYCERIN	PDC6A3C0OX	GEL / TRANSDERMAL		500 mg	Exact identifier — unii candidate 75 equally ranked IID candidates
POLYETHYLENE GLYCOL 1000	POLYETHYLENE GLYCOL 1000	U076Q6Q621	TABLET, FILM COATED / ORAL	1.52 mg		Exact identifier — unii candidate 9 equally ranked IID candidates
POLYETHYLENE GLYCOL 1000	POLYETHYLENE GLYCOL 1000	U076Q6Q621	SOLUTION / ORAL	1000 mg/5ml		Exact identifier — unii candidate 9 equally ranked IID candidates
GLYCINE	GLYCINE	TE7660XO1C	TABLET, ORALLY DISINTEGRATING / ORAL		60 mg	Exact identifier — unii candidate 20 equally ranked IID candidates
GLYCERIN	GLYCERIN	PDC6A3C0OX	INJECTION / INTRAVENOUS		33750 mg	Exact identifier — unii candidate 75 equally ranked IID candidates
POLYETHYLENE GLYCOL 1000	POLYETHYLENE GLYCOL 1000	U076Q6Q621	GEL / TOPICAL		50 mg	Exact identifier — unii candidate 9 equally ranked IID candidates
POLYETHYLENE GLYCOL 1000	POLYETHYLENE GLYCOL 1000	U076Q6Q621	AEROSOL, FOAM / TOPICAL	NA		Exact identifier — unii candidate 9 equally ranked IID candidates
GLYCERIN	GLYCERIN	PDC6A3C0OX	AEROSOL, FOAM / TOPICAL		21 mg	Exact identifier — unii candidate 75 equally ranked IID candidates
SODIUM POLYMETAPHOSPHATE	SODIUM POLYMETAPHOSPHATE	P1BM4ZH95L	SUSPENSION / ORAL	1 mg/1ml		Exact identifier — unii candidate 2 equally ranked IID candidates
XANTHAN GUM	XANTHAN GUM	TTV12P4NEE	TABLET, CHEWABLE, EXTENDED RELEASE / ORAL		6 mg	Exact identifier — unii candidate 29 equally ranked IID candidates
POLYSORBATE 60	POLYSORBATE 60	CAL22UVI4M	LOTION / TOPICAL	5 %w/w		Exact identifier — unii candidate 13 equally ranked IID candidates
BUTYLATED HYDROXYTOLUENE	BUTYLATED HYDROXYTOLUENE	1P9D0Z171K	AEROSOL, FOAM / TOPICAL		4 mg	Exact identifier — unii candidate 32 equally ranked IID candidates
TROLAMINE	TROLAMINE	9O3K93S3TK	SPRAY / NASAL	NA		Exact identifier — unii candidate 22 equally ranked IID candidates
POLYSORBATE 60	POLYSORBATE 60	CAL22UVI4M	SHAMPOO / TOPICAL	14.55 %w/w		Exact identifier — unii candidate 13 equally ranked IID candidates
BUTYLATED HYDROXYTOLUENE	BUTYLATED HYDROXYTOLUENE	1P9D0Z171K	OINTMENT / TOPICAL		57 mg	Exact identifier — unii candidate 32 equally ranked IID candidates
GLYCINE	GLYCINE	TE7660XO1C	INJECTION, POWDER, FOR SOLUTION / SUBCUTANEOUS	0.5 mg		Exact identifier — unii candidate 20 equally ranked IID candidates
GLYCERIN	GLYCERIN	PDC6A3C0OX	TABLET, COATED / ORAL	1 mg		Exact identifier — unii candidate 75 equally ranked IID candidates
ALCOHOL	ALCOHOL	3K9958V90M	GEL / TOPICAL		9971 mg	Exact identifier — unii candidate 59 equally ranked IID candidates
TROLAMINE	TROLAMINE	9O3K93S3TK	CREAM / VAGINAL		56 mg	Exact identifier — unii candidate 22 equally ranked IID candidates
GLYCERIN	GLYCERIN	PDC6A3C0OX	INJECTION, SOLUTION / INTRAMUSCULAR	15 %w/v		Exact identifier — unii candidate 75 equally ranked IID candidates
GLYCERIN	GLYCERIN	PDC6A3C0OX	JELLY / TOPICAL	NA		Exact identifier — unii candidate 75 equally ranked IID candidates
FERRIC OXIDE RED	FERRIC OXIDE RED	1K09F3G675	CAPSULE / ORAL		5 mg	Exact identifier — unii candidate 21 equally ranked IID candidates
XANTHAN GUM	XANTHAN GUM	TTV12P4NEE	GRANULE, FOR SUSPENSION / ORAL		450 mg	Exact identifier — unii candidate 29 equally ranked IID candidates
GLYCERIN	GLYCERIN	PDC6A3C0OX	SOLUTION, CONCENTRATE / ORAL	200 mg/1ml		Exact identifier — unii candidate 75 equally ranked IID candidates
POLYSORBATE 60	POLYSORBATE 60	CAL22UVI4M	EMULSION / ORAL	20 mg/1ml		Exact identifier — unii candidate 13 equally ranked IID candidates
GLYCINE	GLYCINE	TE7660XO1C	CAPSULE, DELAYED RELEASE / ORAL		50 mg	Exact identifier — unii candidate 20 equally ranked IID candidates
FERRIC OXIDE RED	FERRIC OXIDE RED	1K09F3G675	TABLET, FILM COATED, EXTENDED RELEASE / ORAL	3.6 mg		Exact identifier — unii candidate 21 equally ranked IID candidates
ALCOHOL	ALCOHOL	3K9958V90M	INJECTION / SUBCUTANEOUS		149 mg	Exact identifier — unii candidate 59 equally ranked IID candidates
PHENOXYETHANOL	PHENOXYETHANOL	HIE492ZZ3T	LOTION / TOPICAL	1 %w/w		Exact identifier — unii candidate 6 equally ranked IID candidates
FERRIC OXIDE YELLOW	FERRIC OXIDE YELLOW	EX438O2MRT	TABLET, CHEWABLE / ORAL		14 mg	Exact identifier — unii candidate 20 equally ranked IID candidates
GLYCERIN	GLYCERIN	PDC6A3C0OX	SPRAY / NASAL	22.3 mg/1ml		Exact identifier — unii candidate 75 equally ranked IID candidates
GLYCINE	GLYCINE	TE7660XO1C	INJECTION, SOLUTION / INTRAVENOUS	0.42 %w/v		Exact identifier — unii candidate 20 equally ranked IID candidates
ALCOHOL	ALCOHOL	3K9958V90M	TABLET, DELAYED RELEASE / ORAL	NA		Exact identifier — unii candidate 59 equally ranked IID candidates
BUTYLATED HYDROXYTOLUENE	BUTYLATED HYDROXYTOLUENE	1P9D0Z171K	GEL, METERED / TOPICAL		4 mg	Exact identifier — unii candidate 32 equally ranked IID candidates
GLYCERIN	GLYCERIN	PDC6A3C0OX	EMULSION / INTRAVENOUS	2.2 %w/v		Exact identifier — unii candidate 75 equally ranked IID candidates
GLYCERYL MONOSTEARATE	GLYCERYL MONOSTEARATE	230OU9XXE4	EMULSION / ORAL	NA		Exact identifier — unii candidate 21 equally ranked IID candidates
GLYCERIN	GLYCERIN	PDC6A3C0OX	SOLUTION / TOPICAL		1971 mg	Exact identifier — unii candidate 75 equally ranked IID candidates
GLYCERIN	GLYCERIN	PDC6A3C0OX	SOLUTION / DENTAL	15 %w/v		Exact identifier — unii candidate 75 equally ranked IID candidates
GLYCERIN	GLYCERIN	PDC6A3C0OX	ELIXIR / ORAL		5621 mg	Exact identifier — unii candidate 75 equally ranked IID candidates
GLYCERIN	GLYCERIN	PDC6A3C0OX	LIQUID / ORAL		2400 mg	Exact identifier — unii candidate 75 equally ranked IID candidates
ALCOHOL	ALCOHOL	3K9958V90M	AEROSOL, SPRAY / TOPICAL		561 mg	Exact identifier — unii candidate 59 equally ranked IID candidates
GLYCERIN	GLYCERIN	PDC6A3C0OX	FILM, EXTENDED RELEASE / BUCCAL		34 mg	Exact identifier — unii candidate 75 equally ranked IID candidates
POLYSORBATE 60	POLYSORBATE 60	CAL22UVI4M	AEROSOL, FOAM / TOPICAL		30 mg	Exact identifier — unii candidate 13 equally ranked IID candidates
ALCOHOL	ALCOHOL	3K9958V90M	SPRAY, METERED / SUBLINGUAL		29 mg	Exact identifier — unii candidate 59 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	POWDER, FOR SOLUTION / ORAL		280 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
BUTYLATED HYDROXYTOLUENE	BUTYLATED HYDROXYTOLUENE	1P9D0Z171K	INJECTION / INTRAVENOUS	NA		Exact identifier — unii candidate 32 equally ranked IID candidates
GLYCERYL MONOSTEARATE	GLYCERYL MONOSTEARATE	230OU9XXE4	SUPPOSITORY / RECTAL	35 mg		Exact identifier — unii candidate 21 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
b2ea8c5e-0cdc-4be6-9d7f-9a5812c65319			1e5f76e2-8d07-400a-9365-7abdcc13b3d8	2023-10-18	Warnings	Exact identifier spl set id: 1e5f76e2-8d07-400a-9365-7abdcc13b3d8

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.